Movement Alert｜Alibaba Health Rises 3.03% in Regular Trading, Pharma E-commerce Sector Rebounds After Consecutive Sell-off

Market Focus07-15 11:14

On July 15, Alibaba Health rose 3.03% in regular trading, trading at 3.39 HKD/share, with turnover of HKD 206 million. The stock rebounded after two consecutive days of significant declines that had driven it near a low of 3.16 HKD, approaching UBS's sell target price of 3.1 HKD before attracting buying support.

The broader Internet and direct marketing retail sector rallied today, with peers JD Health up 2.16%, Alibaba up 2.8%, and Meituan up 5.93%, providing a clear lift through sector linkage. The rebound follows a period of heavy selling pressure that weighed on the pharma e-commerce space, during which southbound capital had cumulatively reduced holdings by over 128 million shares over the prior 20 trading days.

On the ratings front, Bank of America Securities and Jefferies both maintain Buy ratings on Alibaba Health with target prices of 5.1 HKD and 5.3 HKD respectively, significantly above the current trading level, while UBS holds a contrarian Sell rating at 3.1 HKD. This bull-bear divergence has prompted selective bargain-hunting by some funds near technical support levels.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1171773759?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-15 11:14","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1171773759","market":"us","top_or_hot":-1,"title":"Movement Alert｜Alibaba Health Rises 3.03% in Regular Trading, Pharma E-commerce Sector Rebounds After Consecutive Sell-off","media":"Market Focus","content":"<p><p>On July 15, Alibaba Health rose 3.03% in regular trading, trading at 3.39 HKD/share, with turnover of HKD 206 million. The stock rebounded after two consecutive days of significant declines that had driven it near a low of 3.16 HKD, approaching UBS's sell target price of 3.1 HKD before attracting buying support.</p><p>The broader Internet and direct marketing retail sector rallied today, with peers JD Health up 2.16%, Alibaba up 2.8%, and Meituan up 5.93%, providing a clear lift through sector linkage. The rebound follows a period of heavy selling pressure that weighed on the pharma e-commerce space, during which southbound capital had cumulatively reduced holdings by over 128 million shares over the prior 20 trading days.</p><p>On the ratings front, Bank of America Securities and Jefferies both maintain Buy ratings on Alibaba Health with target prices of 5.1 HKD and 5.3 HKD respectively, significantly above the current trading level, while UBS holds a contrarian Sell rating at 3.1 HKD. This bull-bear divergence has prompted selective bargain-hunting by some funds near technical support levels.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜Alibaba Health Rises 3.03% in Regular Trading, Pharma E-commerce Sector Rebounds After Consecutive Sell-off</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜Alibaba Health Rises 3.03% in Regular Trading, Pharma E-commerce Sector Rebounds After Consecutive Sell-off\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-07-15 11:14</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On July 15, Alibaba Health rose 3.03% in regular trading, trading at 3.39 HKD/share, with turnover of HKD 206 million. The stock rebounded after two consecutive days of significant declines that had driven it near a low of 3.16 HKD, approaching UBS's sell target price of 3.1 HKD before attracting buying support.</p><p>The broader Internet and direct marketing retail sector rallied today, with peers JD Health up 2.16%, Alibaba up 2.8%, and Meituan up 5.93%, providing a clear lift through sector linkage. The rebound follows a period of heavy selling pressure that weighed on the pharma e-commerce space, during which southbound capital had cumulatively reduced holdings by over 128 million shares over the prior 20 trading days.</p><p>On the ratings front, Bank of America Securities and Jefferies both maintain Buy ratings on Alibaba Health with target prices of 5.1 HKD and 5.3 HKD respectively, significantly above the current trading level, while UBS holds a contrarian Sell rating at 3.1 HKD. This bull-bear divergence has prompted selective bargain-hunting by some funds near technical support levels.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"00241","symbol_name":"阿里健康","start_time":0,"source_url":"","article_id":"1171773759","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1171773759","pubTimestamp":1784085288,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On July 15, Alibaba Health rose 3.03% in regular trading, trading at 3.39 HKD/share, with turnover of HKD 206 million. The stock rebounded after two consecutive days of significant declines that had...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"00241":"阿里健康"},"translate_title":"动向提醒|阿里健康常规交易上涨3.03%，医药电商板块连续抛售后反弹","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"00241":1},"content_text":"On July 15, Alibaba Health rose 3.03% in regular trading, trading at 3.39 HKD/share, with turnover of HKD 206 million. The stock rebounded after two consecutive days of significant declines that had driven it near a low of 3.16 HKD, approaching UBS's sell target price of 3.1 HKD before attracting buying support.The broader Internet and direct marketing retail sector rallied today, with peers JD Health up 2.16%, Alibaba up 2.8%, and Meituan up 5.93%, providing a clear lift through sector linkage. The rebound follows a period of heavy selling pressure that weighed on the pharma e-commerce space, during which southbound capital had cumulatively reduced holdings by over 128 million shares over the prior 20 trading days.On the ratings front, Bank of America Securities and Jefferies both maintain Buy ratings on Alibaba Health with target prices of 5.1 HKD and 5.3 HKD respectively, significantly above the current trading level, while UBS holds a contrarian Sell rating at 3.1 HKD. This bull-bear divergence has prompted selective bargain-hunting by some funds near technical support levels.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.45.2","shortVersion":"4.45.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1171773759","isCrawlerRequest":true}